Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · IEX Real-Time Price · USD
1.530
-0.060 (-3.77%)
At close: May 17, 2024, 4:00 PM
1.500
-0.030 (-1.96%)
After-hours: May 17, 2024, 4:03 PM EDT
Sensei Biotherapeutics Market Cap
Sensei Biotherapeutics has a market cap or net worth of $38.37 million as of May 17, 2024. Its market cap has decreased by -16.94% in one year.
Market Cap
38.37M
Enterprise Value
-14.07M
1-Year Change
-16.94%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since the IPO on February 4, 2021, Sensei Biotherapeutics's market cap has decreased from $561.61M to $38.37M, a decrease of -93.17%. That is a compound annual growth rate of -55.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 38.40M | -3.76% |
May 16, 2024 | 39.90M | 6.68% |
May 15, 2024 | 37.40M | -1.32% |
May 14, 2024 | 37.90M | -3.81% |
May 13, 2024 | 39.40M | 3.96% |
May 10, 2024 | 37.90M | -3.81% |
May 9, 2024 | 39.40M | -14.53% |
May 8, 2024 | 46.10M | 1.54% |
May 7, 2024 | 45.40M | -1.52% |
May 6, 2024 | 46.10M | 2.67% |
May 3, 2024 | 44.90M | 8.45% |
May 2, 2024 | 41.40M | 31.01% |
May 1, 2024 | 31.60M | 23.44% |
Apr 30, 2024 | 25.60M | - |
Apr 29, 2024 | 25.60M | - |
Apr 26, 2024 | 25.60M | 1.99% |
Apr 25, 2024 | 25.10M | 0.80% |
Apr 24, 2024 | 24.90M | -0.40% |
Apr 23, 2024 | 25.00M | 7.30% |
Apr 22, 2024 | 23.30M | -4.12% |
Apr 19, 2024 | 24.30M | -1.22% |
Apr 18, 2024 | 24.60M | -1.99% |
Apr 17, 2024 | 25.10M | 1.21% |
Apr 16, 2024 | 24.80M | -1.59% |
Apr 15, 2024 | 25.20M | -4.18% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
OncoCyte | 39.49M |
Unicycive Therapeutics | 39.49M |
Quince Therapeutics | 38.89M |
Precision Optics Corporation | 38.84M |
Achilles Therapeutics | 38.40M |
American Oncology Network | 38.29M |
Estrella Immunopharma | 38.07M |
NRx Pharmaceuticals | 37.77M |